نتایج جستجو برای: Mesna

تعداد نتایج: 2537  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1998
M P Goren J M Houle D A Bush J T Li C E Newman W P Brade

Although mesna has been used for more than a decade to reduce the incidence of hemorrhagic cystitis induced by ifosfamide and cyclophosphamide, the disposition of i.v. and oral mesna has not been adequately described. To obtain accurate bioavailability data for the design of mesna regimens, we developed procedures to preserve and measure mesna and dimesna in the blood and urine and studied 25 v...

Journal: :Molecular medicine reports 2015
Sheng Chen Nianhai He Jialin Yu Luquan Li Fengjun Sun Ying Hu Rui Deng Shiming Zhong Leilei Shen

The biofilms (BF) formed by Escherichia coli (E. coli) is an important cause of chronic and recurrent infections due to its capacity to persist on medical surfaces and indwelling devices, demonstrating the importance of inhibiting the formation of E. coli BF and reducing BF infection. Although 2‑mercaptoethane sulfonate (MESNA) exhibits a marked mucolytic effect clinically, the effect of MESNA ...

Journal: :Thorax 1986
J Stolk J A Kramps J H Dijkman

We have studied the effects of the mucolytic thiol agent mercapto-ethanesulphonate (mesna) on the activity of both polymorphonuclear leucocyte (PMN) elastase and antileucoprotease in vitro. In all tests a specific synthetic substrate was used to measure elastase activity, which was then related to enzyme activity in the absence of mesna. The relative elastase activity decreased to 67.5% of cont...

Journal: :The journal of international advanced otology 2017
Oğuz Kadir Eğilmez Numan Kökten Mustafa Baran M Tayyar Kalcıoğlu Işın Doğan Ekici Muhammet Tekin

OBJECTIVE Sodium-2-mercaptoethanesulfonate (MESNA) is widely used in medicine because of its antioxidant and mucolytic effects. In recent years, it has been used in otologic surgery. Because it cleaves disulfide bonds, it is used to easily dissect the epithelial matrix in cholesteatoma and atelectasis. In this study, we hypothesized that MESNA does not have any toxic effect on the facial nerve,...

Journal: :Archives of disease in childhood 1983
D P Heaf G J Webb D J Matthew

The minimal inhibitory concentration of azlocillin for Pseudomonas aeruginosa is appreciably reduced when combined with the mucolytic agent mesna (Mistabron) because of an independent bacteriostatic effect of mesna. Bactericidal activity of azlocillin is unaltered by mesna. Mesna inhalations alone or combined with azlocillin may benefit cystic fibrosis patients with pseudomonas lung infections.

Journal: :Clinical journal of the American Society of Nephrology : CJASN 2008
Bradley L Urquhart David J Freeman Murray J Cutler Rahul Mainra J David Spence Andrew A House

BACKGROUND AND OBJECTIVES Increased plasma total homocysteine is a graded, independent risk factor for the development of atherosclerosis and thrombosis. More than 90% of patients with end-stage renal disease have hyperhomocysteinemia despite vitamin supplementation. It was shown in previous studies that a single intravenous dose of mesna 5 mg/kg caused a drop in plasma total homocysteine that ...

2013
N. Kanai M. Yamato T. Hosoi N. Tanaka T. Okano S. Eguchi Y. Sato R. Morita M. Suzuki S. Nakatsu S. Ishigooka S. - I. Ozawa K. Hosoya H. Yasuda F. Itoh R. Del Valle H. Pitanga Lukashok C. Robles - Jara S. - E. Kudo N. Ikehara K. Wakamura K. Ichimasa K. - I. Takeda M. Misawa T. Kudo Y. Wada T. Hayashi H. Miyachi H. Inoue

INTRODUCTION: In Western countries, ESD was not commonly performed because the submocosal dissection is technically challenging. We reported that the injection of mesna solution (sodium-2-mercaptoethanesulfonate) made submucosal connective tissues chemically softened and facilitated mechanical dissection of the submucosal layer in the stomach [1]. Our previous study suggested that mechanical di...

2006
Marshall P. Goren Li C. Hsu Jackie T. Li

Mesna is administered with ifosfamide and cyclophosphamide to re duce the incidence of hemorrhagic cystitis. In the present model of mesna metabolism and disposition, mesna is rapidly and irreversibly oxidized to dimesna in the plasma, passes unchanged through the liver, and is then reduced by the kidney and excreted. Our detection of a high ratio of mesna to dimesna in the plasma of clinical s...

2006
Marshall P. Goren Charles B. Pratt William H. Meyer Reba K. Wright Richard K. Dodge Mary J. Viar

To characterize the excretion of 2-mercaptoethanesulfonate sodium (mesna) administered by intermittent infusion, urinary concentrations of mesna and its corresponding inactive disulfide »eremeasured during 50 courses of ifosfamide (1.6 g/nr for 5 days) and mesna (400 mg/nr at 0.25, 4, and 6 h after each ifosfamide dose) administered i.v. to 19 patients. Some patients had previously received ne...

Journal: :Cancer research 1998
M P Goren L C Hsu J T Li

Mesna is administered with ifosfamide and cyclophosphamide to reduce the incidence of hemorrhagic cystitis. In the present model of mesna metabolism and disposition, mesna is rapidly and irreversibly oxidized to dimesna in the plasma, passes unchanged through the liver, and is then reduced by the kidney and excreted. Our detection of a high ratio of mesna to dimesna in the plasma of clinical sa...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید